Assessing subject diversity by condition and trial phase in clinical trials

被引：1
|
作者：
Gorrepati, Pavane L. [1 ]
Smith, Gideon P. [1 ]
机构：
[1] Massachusetts Gen Hosp, Dept Dermatol, Boston, MA 02114 USA
来源：
INTERNATIONAL JOURNAL OF DERMATOLOGY | 2023年 / 62卷 / 02期
关键词：
D O I：
10.1111/ijd.16043
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：E65 / E67
页数：3
相关论文
共 50 条
  • [1] Assessing Participant Diversity in Acne Clinical Trials
    Gupta, Rohit
    Roy, Cayla
    Doan, Hung Q.
    JOURNAL OF DRUGS IN DERMATOLOGY, 2022, 21 (07) : 797 - 798
  • [2] Assessing Compliance and Diversity in Early Phase Radiation Oncology Clinical Trials in the United States
    Rezaei, S. A.
    Price, A. T.
    McClelland, S., III
    Henke, L. E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E59 - E59
  • [3] ASSESSING CLINICAL-TRIALS - TRIAL SIZE
    ANDERSSON, N
    ARMSTRONG, B
    COCKCROFT, A
    BRITISH MEDICAL JOURNAL, 1981, 282 (6279): : 1872 - 1873
  • [4] ASSESSING CLINICAL-TRIALS - TRIAL SIZE
    GORE, SM
    BMJ-BRITISH MEDICAL JOURNAL, 1981, 282 (6277): : 1687 - 1689
  • [5] ASSESSING THE IMPLEMENTABILITY OF REGULATORY AGENCIES' GUIDANCE ON DIVERSITY IN CLINICAL TRIALS
    Metcalfe, R.
    Reshef, S.
    Park, J.
    VALUE IN HEALTH, 2024, 27 (06) : S209 - S209
  • [6] STATISTICS IN QUESTION - ASSESSING CLINICAL-TRIALS - TRIAL DISCIPLINE
    GORE, SM
    BRITISH MEDICAL JOURNAL, 1981, 283 (6285): : 211 - 213
  • [7] Clinical Trial Diversity: Outcomes for US patients with advanced cancer in Phase 1 clinical trials at a major cancer center
    Davidson, Tara M.
    Roszik, Jason
    Kang, Lei
    Le, Hung
    Campbell, Erick
    Ozenne, Cherri
    Dumbrava, Ecatarina Cathy
    Fu, Siquing
    Hong, David S.
    Karp, Daniel D.
    Naing, Aung
    Piha-Paul, Sarina A.
    Rodon, Jordi
    Tsimberidou, Apostolia M.
    Yap, Timothy A.
    Meric-Bernstam, Funda
    Subbiah, Vivek
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2023, 32 (12)
  • [8] A Protected Class, An Unprotected Condition, and A Biomarker - A Method/Formula for Increased Diversity in Clinical Trials for the African American Subject with Benign Ethnic Neutropenia (BEN)
    Ponder, Regina
    AMERICAN JOURNAL OF LAW & MEDICINE, 2023, 49 (01) : 41 - 58
  • [9] Clinical trials - In critical condition
    Marshall, E
    SCIENCE, 2003, 300 (5623) : 1225 - 1226
  • [10] Assessing Repair in Multiple Sclerosis: Outcomes for Phase II Clinical Trials
    Sormani, Maria Pia
    Pardini, Matteo
    NEUROTHERAPEUTICS, 2017, 14 (04) : 924 - 933
12345